Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis Paloma López-Beret, MD, Antonio Orgaz, MD, Juan Fontcuberta, MD, Manuel Doblas, MD, Adela Martinez, RVT, Gloria Lozano, RVT, Arturo Romero, MD Journal of Vascular Surgery Volume 33, Issue 1, Pages 77-90 (January 2001) DOI: 10.1067/mva.2001.109336 Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 1 Complications after long-term treatment of DVT. LMWH, Low molecular weight heparin; NS, not statistically significant; OA, oral anticoagulant. Journal of Vascular Surgery 2001 33, 77-90DOI: (10.1067/mva.2001.109336) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 2 Effect of both treatments on the evaluation of thrombosis expressed by quantitative duplex scan score according to DVT level. DVT, Deep venous thrombosis; LMWH, low molecular weight heparin; NS, not significant; OA, oral anticoagulant; *statistically significant. Journal of Vascular Surgery 2001 33, 77-90DOI: (10.1067/mva.2001.109336) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 3 Regression of thrombus size according to duplex scan examination in proximal venous segments. LMWH, Low molecular weight heparin; NS, Not significant; OA, oral anticoagulant; *statistically significant. Journal of Vascular Surgery 2001 33, 77-90DOI: (10.1067/mva.2001.109336) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions